Beta Bionics Inc stock is traded at $13.36, with a volume of 960,302. It is up +0.30% in the last 24 hours and down -24.69% over the past month. Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Previous Close:
$13.32
Open:
$13.05
24h Volume:
960,302
Relative Volume:
0.89
Market Cap:
$726.34M
Revenue:
$110.24M
Net Income/Loss:
-$66.44M
P/E Ratio:
-
EPS:
-$1.51
Net Cash Flow:
-$61.12M
1W Performance:
-18.64%
1M Performance:
-24.69%
6M Performance:
+32.15%
1Y Performance:
-52.96%
1-Day Range:
$12.92$13.85
1-Week Range:
$12.92$17.19
52-Week Range:
$8.80$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics IncSector
HealthcareIndustry
Medical DevicesPhone
949-427-7785Address
11 HUGHES, IRVINE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS